Search

Your search keyword '"Mangiacapra, F."' showing total 261 results

Search Constraints

Start Over You searched for: Author "Mangiacapra, F." Remove constraint Author: "Mangiacapra, F."
261 results on '"Mangiacapra, F."'

Search Results

1. Prevalence and predictive role of hypertriglyceridemia in statin-treated patients at very high risk: Insights from the START study

2. Prevalence and predictive role of hypertriglyceridemia in statin-treated patients at very high risk: insights from the START Study

3. COMPASS criteria applied to a contemporary cohort of unselected patients with stable coronary artery diseases: Insights from the STARTregistry

5. COMPASS criteria applied to a contemporary cohort of unselected patients with stable coronary artery diseases: Insights from the STARTregistry

10. Impact of Chronic Kidney Disease and Platelet Reactivity on Clinical Outcomes Following Percutaneous Coronary Intervention

11. Clinical outcomes, pharmacological treatment, and quality of life of patients with stable coronary artery diseases managed by cardiologists: 1-year results of the START study

12. Role of endothelial dysfunction in determining angina after percutaneous coronary intervention: Learning from pathophysiology to optimize treatment

15. Endothelial dysfunction as predictor of angina recurrence after successful percutaneous coronary intervention using second generation drug eluting stents

18. P454Validation of a new LVH ECG criterion in a single center wide population

19. Design and rationale for the Minimizing Adverse haemorrhagic events by TRansradial access site and systemic Implementation of angioX program

20. Platelet function and long-term antiplatelet therapy in women: is there a gender-specificity? A 'state-of-the-art' paper

21. 2870Glycemic variability assessed by continuous glucose monitoring and antiplatelet responsiveness in patients undergoing coronary stenting: results from the observational GLYVAR study

23. Synergistic effect of thrombus aspiration and abciximab in primary percutaneous coronary intervention

24. A therapeutic window for platelet reactivity for patients undergoing elective percutaneous coronary intervention: results of the ARMYDA-PROVE (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty-Platelet Reactivity for Outcome Validation Effort) study

25. The role of fractional flow reserve to guide stent implantation

26. Outcome comparison of 600- and 300-mg loading doses of clopidogrel in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: results from the ARMYDA-6 MI (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty-Myocardial Infarction) randomized study

35. Clopidogrel reloading in patients undergoing percutaneous coronary intervention on chronic clopidogrel therapy: results of the ARMYDA-4 RELOAD (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty) randomized trial

41. Effectiveness of in-laboratory high-dose clopidogrel loading versus routine pre-load in patients undergoing percutaneous coronary intervention: Results of the ARMYDA-5 PRELOAD (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty) randomized trial

Catalog

Books, media, physical & digital resources